This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its PharmaceuticalDiagnostics segment. For the period (end-September 30), GEHC had total revenues of $4.86 billion, flat compared with $4.82 last year to 16.3%
Meanwhile, the Ultrasound segment generated revenues of $823 million, down 1% on an organic basis over the same period a year ago. The company’s PharmaceuticalDiagnostics segment generated $639 million in second-quarter revenues, a 14% increase on an organic basis over last year, GE HealthCare reported.
Ultrasound In ultrasound developments, GEHC discussed the addition of Caption Guidance AI software to its Venue family of point-of-care ultrasound systems. Other ultrasound scanners on display included GEHC’s Logiq E10, Fortis, Invenia ABUS 2.0, The system was developed by GEHC company BK Medical.
Campione also joins the Blue Earth Diagnostics Ltd. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Board of Directors.
christine.book Thu, 03/21/2024 - 10:34 March 21, 2024 — Diagnostic imaging provider US Radiology Specialists has announced that Lee Cooper will become its new Chief Executive Officer (CEO), and that current board member Molly Joseph will become its next Board Chair. Cooper and Joseph will succeed John Perkins , U.S.
announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceuticaldiagnostics, and digital portfolio. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided Biopsy Using Local Anesthesia.
milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceuticaldiagnostics, and digital solutions innovator, and MediView XR Inc.,
I’m excited to see our Senographe Pristina mammography system, SenoBright HD CEM technology and contrast media from our PharmaceuticalDiagnostics segment being used to further evaluate the clinical benefits of CEM as part of our efforts to improve breast cancer outcomes.” Breast Cancer Facts and Statistics. Available at: [link].
Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. Diagnostic and Interventional Radiology , December 2006, Vol. Sadowski said that MR can be avoided altogether by using ultrasound, CT, or molecular imaging. It has to be millions," she explained. Giles, U.K.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content